Slate Path Capital LP

Holdings History for Tvardi Therapeutics, Inc. - Common Stock, par value $0.001 per share (TVRD)

Symbol: TVRD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 704,118 shares
Security Ownership %: 7.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Slate Path Capital LP ownership in Tvardi Therapeutics, Inc. Common Stock, par value $0.001 per share (TVRD)

14 Aug 2025 - Slate Path Capital LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 704,118 shares of Tvardi Therapeutics, Inc. Common Stock, par value $0.001 per share (TVRD). This represents 7.5% ownership of the company. This is the first filing by Slate Path Capital LP disclosing ownership of Tvardi Therapeutics, Inc. Common Stock, par value $0.001 per share (TVRD).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Slate Path Capital LP	7.5%		$19,257,627	704,118			$27.35	13G	30 Jun 2025	14 Aug 2025, 16:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.04%	0%	$3,027,707	704,118	0		$4.30	Q4 2025
30 Sep 2025	0.42%	0%	$27,439,478	704,118	0		$38.97	Q3 2025
30 Jun 2025	0.28%	+0.28%	$16,427,073	704,118	+704,118	NEW	$23.33	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.